Veracyte, Inc.
NASDAQ:VCYT
32.92 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 361.051 | 296.536 | 219.514 | 117.483 | 120.368 | 92.008 | 71.953 | 65.085 | 49.503 | 38.19 | 21.884 | 11.628 | 2.645 |
| Cost of Revenue
| 137.899 | 101.582 | 74.4 | 41.455 | 36.523 | 33.078 | 28.195 | 25.462 | 21.497 | 16.606 | 12.607 | 7.584 | 2.925 |
| Gross Profit
| 223.152 | 194.954 | 145.114 | 76.028 | 83.845 | 58.93 | 43.758 | 39.623 | 28.006 | 21.584 | 9.277 | 4.044 | -0.28 |
| Gross Profit Ratio
| 0.618 | 0.657 | 0.661 | 0.647 | 0.697 | 0.64 | 0.608 | 0.609 | 0.566 | 0.565 | 0.424 | 0.348 | -0.106 |
| Reseach & Development Expenses
| 56.366 | 40.603 | 29.843 | 17.204 | 14.851 | 14.82 | 13.881 | 15.324 | 12.796 | 9.804 | 7.81 | 6.608 | 6.68 |
| General & Administrative Expenses
| 157.628 | 76.518 | 101.353 | 36.729 | 29.029 | 23.963 | 23.088 | 23.787 | 22.583 | 18.854 | 12.1 | 7.918 | 5.372 |
| Selling & Marketing Expenses
| 26.604 | 97.56 | 79.84 | 52.389 | 53.691 | 41.313 | 32.26 | 28.248 | 25.293 | 21.932 | 12.54 | 8.447 | 2.934 |
| SG&A
| 178.849 | 174.078 | 181.193 | 89.118 | 82.72 | 65.276 | 55.348 | 52.035 | 47.876 | 40.786 | 24.64 | 16.365 | 8.306 |
| Other Expenses
| 0.56 | 21.354 | 15.981 | 5.095 | 1.401 | 1.197 | 0.476 | 0.202 | 0.14 | 0.072 | -2.179 | 0.278 | 0.819 |
| Operating Expenses
| 235.215 | 236.035 | 227.017 | 111.417 | 98.972 | 81.163 | 70.296 | 68.426 | 61.472 | 50.59 | 32.45 | 22.973 | 14.986 |
| Operating Income
| -12.063 | -41.081 | -81.903 | -35.389 | -15.127 | -22.233 | -26.538 | -28.803 | -33.466 | -29.006 | -23.173 | -18.929 | -15.266 |
| Operating Income Ratio
| -0.033 | -0.139 | -0.373 | -0.301 | -0.126 | -0.242 | -0.369 | -0.443 | -0.676 | -0.76 | -1.059 | -1.628 | -5.772 |
| Total Other Income Expenses Net
| -64.549 | 4.654 | 0.254 | 0.48 | 2.528 | 1.197 | 0.476 | 0.202 | 0.14 | 0.072 | -2.179 | 0.278 | 0.819 |
| Income Before Tax
| -76.612 | -36.427 | -81.649 | -34.909 | -12.599 | -22.999 | -31.003 | -31.358 | -33.704 | -29.373 | -25.58 | -18.649 | -14.445 |
| Income Before Tax Ratio
| -0.212 | -0.123 | -0.372 | -0.297 | -0.105 | -0.25 | -0.431 | -0.482 | -0.681 | -0.769 | -1.169 | -1.604 | -5.461 |
| Income Tax Expense
| -2.208 | 0.133 | -6.086 | 0.938 | 3.882 | 1.197 | 5.417 | 2.959 | 0.518 | -0.664 | -2.945 | -0.002 | 0.819 |
| Net Income
| -74.404 | -36.56 | -75.563 | -35.847 | -16.481 | -22.999 | -31.003 | -31.358 | -33.704 | -29.373 | -25.58 | -18.649 | -14.445 |
| Net Income Ratio
| -0.206 | -0.123 | -0.344 | -0.305 | -0.137 | -0.25 | -0.431 | -0.482 | -0.681 | -0.769 | -1.169 | -1.604 | -5.461 |
| EPS
| -1.02 | -0.51 | -1.11 | -0.67 | -0.36 | -0.62 | -0.91 | -1.09 | -1.3 | -1.36 | -6.15 | -1.31 | -1.02 |
| EPS Diluted
| -1.02 | -0.51 | -1.11 | -0.67 | -0.36 | -0.62 | -0.91 | -1.09 | -1.3 | -1.36 | -6.15 | -1.31 | -1.02 |
| EBITDA
| 15.125 | -15.153 | -62.31 | -26.736 | -7.805 | -17.116 | -22.221 | -27.534 | -32.526 | -28.934 | -25.347 | -18.223 | -13.834 |
| EBITDA Ratio
| 0.042 | -0.051 | -0.284 | -0.228 | -0.065 | -0.186 | -0.309 | -0.423 | -0.657 | -0.758 | -1.158 | -1.567 | -5.23 |